Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Erlotinib (Primary) ; Pemetrexed (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 16 Jan 2018 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record